("Futura" or "the Company")
Posting of Circular and Notice of General Meeting
Further to the Company's announcement of 19 October 2018 that it has conditionally raised £5.6 million before fees and expenses through a successful Placing, Subscription and PrimaryBid Offer with certain existing and new institutional and other investors and up to a further £1.0 million via an Open Offer, Futura confirms that the Circular (containing a notice convening the General Meeting) is today being posted to Shareholders and will shortly be available for download on the Company's website: www.futuramedical.com.
The General Meeting has been convened for 12 November 2018 at 1 p.m. at the offices of Futura Medical plc, Surrey Technology Centre, 40 Occam Road, Guildford, Surrey GU2 7YG .
For further information please contact:
Futura Medical plc |
+44 (0) 1483 685 670 |
||
James Barder, Chief Executive Officer Angela Hildreth, Finance Director & Chief Operating Officer |
investor.relations@futuramedical.com |
||
N+1 Singer |
+44 (0) 207 496 3000 |
||
Aubrey Powell / Jen Boorer (Corporate Finance) Tom Salvesen (Corporate Broking) |
|
||
For media enquiries please contact Optimum Strategic Communications |
+44 (0) 20 3950 9144 futuramedical@optimumcomms.com |
||
Mary Clark / Hollie Vile /Ellie Blackwell |
|
|
|
Capitalised terms used in this announcement shall, unless defined in this announcement or unless the context provides otherwise, bear the same meaning ascribed to such terms in the announcement made by the Company on 18 October 2018 to announce the launch of the Fundraising.